Inclusion Criteria:  All patients who received at least one ADI-001 cell therapy administration and have either discontinued early or completed the core treatment protocol All patients who are willing and able to adhere to the study visit schedule and other protocol requirements. Capable of giving signed informed consent which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and protocol  Exclusion Criteria:  There are no specific exclusion criteria for this study